Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR 2012: Partnership Between Physician and Patient

Thomas R. Collins  |  Issue: September 2012  |  September 5, 2012

The main symptoms—including pain, fatigue, and a feeling of stress—are not easily measured and can be difficult to describe to doctors, she said.

“It comes back to having the trust, creating the work relationship with your specialist,” she said. In the end, patients have to be their own best advocates, she said. “We have to be much better at understanding, and also presenting our diseases.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Scleroderma

Ann Tyrrell Kennedy, president of the Federation of European Scleroderma Associations (FESCA), said a major problem with scleroderma, which often involves physical disfigurement, is self-stigmatization—a “corrosive” psychological hindrance in which patients distress over their body image and are convinced other people are always staring at them. This makes social interaction difficult.

The disease’s damage to the toes and fingers generates self-consciousness, she said. “The psychological effect can be more devastating than the physical effect,” Kennedy said. “This is rarely given enough attention by clinicians.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A Canadian group has developed a way to assess scleroderma patients’ body image, with a tool called the Brief-Satisfaction with Appearance Scale (Brief-SWAP). Results of a study using this method found a pattern of self-stigmatization. “They show that people who evaluated themselves as disfigured stigmatized themselves, particularly women and the young,” Kennedy said.

She also noted that, while small changes to physical appearance through medical procedures might help a great deal with self-esteem, major overhauls, especially to the face, can lead to problems with self-identity.

Ankylosing Spondylitis

Cor van Drogen, a member of the executive committee of the Ankylosing Spondylitis International Federation, recalled the unpleasant experience of his own diagnosis. His general practitioner didn’t recognize the disease, then an acquaintance, also a doctor, said it might be ankylosing spondylitis (AS).

van Drogen asked his general practitioner for a blood test and an X-ray, only to be told that he didn’t have AS and that those steps were unnecessary. van Drogen insisted, and finally the diagnosis was made by a rheumatologist.

“From that moment, I had another general practitioner,” van Drogen said.

He stressed the value of getting involved with patient-advocate organizations. “The right attitude,” he said, “will help the patient to get along with the disease on an acceptable level.”


Thomas Collins is a freelance medical writer based in Florida.

Page: 1 2 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsEULAR/OtherMeeting ReportsPractice SupportQuality Assurance/ImprovementSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:Ankylosing SpondylitisEULARInternationalLupuspatient carepatient communicationPractice ManagementrheumatologistScleroderma

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Cellular Therapy of Autoimmune Disease

    November 1, 2008

    Is a novel treatment breakthrough on the horizon?

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

    Targeted Therapy for Scleroderma Fibrosis

    October 11, 2016

    Scleroderma, or systemic sclerosis (SSc), is an autoimmune disease characterized by vasculopathy and fibrosis. Although relatively rare, with a prevalence in North America of approximately 300 per 1 million people, SSc is associated with significant morbidity and high rates of mortality.1 Patients with scleroderma have four times greater mortality than age- and sex-matched controls, with…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences